Xconomy National

Archives

by in

Entry	Author	Date	Location
Amgen CEO Kevin Sharer’s Report Card: C	Luke Timmerman	12/19/11	National
Amgen Confirms 380 Layoffs in R&D; Cuts Coming to Seattle, SF, Boston	Luke Timmerman	10/19/11	National
Amgen Looking to Improve Focus and “Re-allocate Resources” for R&D, Say More Oct. 24	Luke Timmerman	10/12/11	National
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing	Arlene Weintraub	05/24/11	Boston
Amgen Passes Key Trial With “Son of Dmab” For Osteoporosis	Luke Timmerman	04/21/11	National
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised	Luke Timmerman	03/14/11	National
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News	Luke Timmerman	02/11/11	San Francisco
Stromedix Adds Debt to Finance Clinical Trial, Eliza and Google Team Up for Health IT Website, Arsanis Gets $10M, & More Boston-Area Life Sciences News	Erin Kutz	02/11/11	Boston
Amgen Pushes Ahead With ‘Son of Dmab’ For Treating Broken, Frail Bones	Luke Timmerman	02/09/11	National
Amgen’s R&D Chief, Roger Perlmutter, on Why BioVex’s Cancer-Fighting Virus Is Worth $1B	Luke Timmerman	01/26/11	Boston
One Big Cancer Story from 2010, and Four Trends to Watch in 2011	David Lacey	01/14/11	San Francisco
Northern California’s Top 5 Biotech Innovation News Stories	Gail Maderis	12/28/10	San Francisco
Dendreon Commercial Guy Leaves, Light Sciences CEO Exits, Amgen Wins FDA OK, & More Seattle-Area Life Sciences News	Luke Timmerman	11/24/10	Seattle
Amgen Wins FDA OK For Cancer Drug	Luke Timmerman	11/18/10	Seattle
Amgen, Abbott Win BayBio Awards	Luke Timmerman	11/05/10	San Francisco
Biotech Drug Discovery in Seattle: A Look Back	Stewart Lyman	06/11/10	Seattle
Amgen Gets FDA Approval, SonoSite’s New Frontier, Craig Venter’s Enabler, & More Seattle-Area Life Sciences News	Luke Timmerman	06/03/10	Seattle
Amgen’s Dmab Wins FDA Approval	Luke Timmerman	06/01/10	Seattle
A Brief Year-End Review of Seattle Biotech	Stewart Lyman	12/31/09	Seattle
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News	Luke Timmerman	10/22/09	Seattle
Amgen’s Dmab Faces FDA Delay	Luke Timmerman	10/19/09	Seattle
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent	Luke Timmerman	10/09/09	National
Amgen’s Dmab Works in Cancer Trial	Luke Timmerman	07/07/09	Seattle
Amgen Shows Off Cancer Drug Pipeline Before Scientific Meeting	Luke Timmerman	04/16/09	National
Amgen Cuts 100 Jobs in Bothell	Luke Timmerman	04/09/09	Seattle
ZymoGenetics Trial Halted, Amgen’s Big New Drug, Spiration Gets FDA Nod, & More Seattle-Area Life Sciences News	Luke Timmerman	10/30/08	Seattle
Amgen Scientist, After 13-Year Push, Sees Bone Cancer Work Paying Dividends	Luke Timmerman	10/29/08	Seattle
Amgen’s Dmab Cuts Fracture Risk for Osteoporosis Patients, Just What Investors Wanted to See	Luke Timmerman	09/16/08	Seattle
Amgen Osteoporosis Drug Reduces Bone Fractures in Pivotal Study	Luke Timmerman	07/25/08	Seattle
Page 1 of 1